Boston researchers identify new mechanism that inhibit tumor growth in mice
A team of researchers, led by Pier Paolo Pandolfi, at Beth Israel Deaconess Medical Center, Boston, has identified a new type of cellular senescence (i.e., irreversible arrest of cell growth) and determined a way to enhance it to suppress prostate tumor development and growth in mice. (Tue, 09 Feb 2010 06:46:51 GMT)
Alnylam Pharmaceuticals receives 'Notice of Allowance' from USPTO
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the “Soutschek and Manoharan” patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery. (Tue, 09 Feb 2010 06:46:41 GMT)
An Early Warning System for Cancer
Autoantibodies could alert doctors to cancer development. A new screening tool developed by scientists in Denmark may help detect the earliest stages of cancer by taking advantage of the body's own defenses. The researchers constructed a microarray system that analyzes patients' blood for a specific class of immune agents called autoantibodies. These are agents that attack the body's own tissue ... (Tue, 09 Feb 2010 05:19:15 GMT)
IBM Launches Eight-core Power7 Processor, Servers
UPDATE: IBM launched its latest eight-core Power7 processor on Monday. (Tue, 09 Feb 2010 04:50:58 GMT)
QIAGEN Acquires Exclusive Licence for Key PI3K gene
VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays. (Tue, 09 Feb 2010 01:14:42 GMT)
NTU research could lead to cure for malaria
RESEARCHERS at Nanyang Technological University's (NTU) School of Biological Sciences have completed the world's first in-depth study of the malaria parasite genome, which could lead to a cure for malaria. (Tue, 09 Feb 2010 01:00:32 GMT)
Method of the future uses single-cell imaging to identify gene interactions
( Cold Spring Harbor Laboratory ) Cellular imaging offers a wealth of data about how cells respond to stimuli, but harnessing this technique to study biological systems is a daunting challenge. In a study published online in Genome Research, researchers have developed a novel method of interpreting data from single-cell images to identify genetic interactions within biological networks, offering ... (Mon, 08 Feb 2010 22:26:20 GMT)
08.02.2010 - PRESS RELEASE: QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results
Qiagen N.V. / QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. (Mon, 08 Feb 2010 22:00:59 GMT)
IBM launches eight-core Power7 processor, servers
IBM on Monday launched its latest Power7 processor, which adds more cores and improved multithreading capabilities to boost the performance of servers requiring high up time. (Mon, 08 Feb 2010 21:25:40 GMT)
QIAGEN Acquires Exclusive Licence for Key PI3K gene
VENLO, The Netherlands, February 8 /PRNewswire/ -- - Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint ... (Mon, 08 Feb 2010 21:11:41 GMT)
QIAGEN Acquires Exclusive Licence for Key PI3K gene
QIAGEN today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays. (Mon, 08 Feb 2010 21:00:00 GMT)
QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results
VENLO, Netherlands -- QIAGEN N.V. today announced the results of operations for the fourth quarter and the fiscal year ended December 31, 2009. (Mon, 08 Feb 2010 21:00:00 GMT)
EU, India to Partner on Joint Research Efforts
NEW YORK (GenomeWeb News) – Several European Union member states will partner with India to create a networking pilot program that will enable the partners to share resources and talent and jointly support new diagnostic and biomarker studies. (Mon, 08 Feb 2010 20:50:29 GMT)
DNAVision Adds Illumina HiSeq to Service Offerings
NEW YORK (GenomeWeb News) – DNAVision, a Belgian genomics services provider, today said that it has purchased one of Illumina's new sequencing instruments, the HiSeq 2000, for its service offerings. (Mon, 08 Feb 2010 20:50:18 GMT)
CDC to Fund Genomics Knowledge Center
NEW YORK (GenomeWeb News) – The Office of Public Health Genomics at the US Centers for Disease Control and Prevention will grant $1.5 million to fund the creation of a center that will help plan and develop systematic evidence reviews on genomics applications, among other efforts. (Mon, 08 Feb 2010 20:50:09 GMT)
Munich Startup Nanotype Forces Its Way into Microarray Market with C-FIT Technology
Finding the right partner is not only a problem that haunts many startup companies. It also may be a major challenge for probe and target molecules on microarrays. (Mon, 08 Feb 2010 17:05:12 GMT)
Looking at Diversity
Researchers are hoping to capture some of the diversity seen in Latin Americans through the new Slim Initiative for Genomic Health between the Broad Institute and Mexico City's Carlos Slim Health Institute, says MIT's Technology Review . That project is still in the planning stages — though it will include gene sequencing and microarray-based studies — but INMEGEN published a Mexican version of ... (Mon, 08 Feb 2010 16:50:19 GMT)
Institute for Systems Biology Mulls Expansion, Focusing on P4 Efforts
SEATTLE — Approaching its 10th anniversary, the Institute for Systems Biology envisions a near-doubling of its faculty, and its space here, in coming years while moving ahead on several collaborations designed to advance "predictive, preventive, personalized, and participatory," medicine, ISB Co-founder and President Leroy Hood told GenomeWeb Daily News in an interview last week. (Mon, 08 Feb 2010 15:50:08 GMT)
Life Sells Mass Spectrometry Business
Life Technologies Corporation recently completed the sale of its mass spectrometry business to Danaher Corporation for $450 million in cash (Mon, 08 Feb 2010 15:35:58 GMT)
March of Dimes Helps Nurses Care for Mothers and Babies
New Continuing Nursing Education Modules Now Available (Mon, 08 Feb 2010 15:30:00 GMT)
Research and Markets: The World Market Report on Biomarkers, Tests and Trends for Drug R&D
DUBLIN----Research and Markets has announced the addition of the "Biomarkers, Tests and Trends for Drug R&D" report to their offering. (Mon, 08 Feb 2010 15:00:00 GMT)
MDRNA, Inc. Reports Positive Results for Its Proprietary siRNA Delivery Technology
Data Demonstrates the Potential for Long-Term Stability of Drug Products (Mon, 08 Feb 2010 13:40:38 GMT)
MDRNA, Inc. Reports Positive Results for Its Proprietary siRNA Delivery Technology
BOTHELL, WA--(Marketwire - 02/08/10) - MDRNA, Inc. (NASDAQ: MRNA - News ), a leading RNAi-based drug discovery and development company, today announced that its lead delivery system formulation demonstrated exceptional stability over a one year period under a variety of conditions. The DiLA2 formulation maintained in vivo knockdown activity with no observed loss in potency over the course of the ... (Mon, 08 Feb 2010 13:30:00 GMT)
Press Release
Molecular Devices Inc. Posted on:05 Feb 10 SUNNYVALE, California, February 3 /PRNewswire/ -- Today, Molecular Devices, Inc.-now part of Danaher Corporation-re-launched the Molecular Devices brand into the life sciences marketplace. (Mon, 08 Feb 2010 13:04:45 GMT)
MDRNA, Inc. Receives Compliance Extension From NASDAQ
BOTHELL, WA--(Marketwire - February 8, 2010) - MDRNA, Inc. ( NASDAQ : MRNA ) announced that it received a letter on February 5, 2010 from The NASDAQ Stock Market, Inc. notifying the Company that, as a result of Securities and Exchanges Commission (SEC) approved changes to NASDAQ Listing Rules, MDRNA now has a grace period of 180 days from its initial notice of non-compliance in which to regain ... (Mon, 08 Feb 2010 12:38:30 GMT)
OGT introduces CytoSure aCGH arrays for detecting disease, syndrome-related aberrations
Oxford Gene Technology (OGT), the pioneer of microarray-based technologies, has introduced three new CytoSure ISCA aCGH arrays to meet all resolutions, multiplexing and budget requirements. (Mon, 08 Feb 2010 11:43:44 GMT)
IDBS Launches Biomarker Discovery and Validation Solution to Accelerate Biomarker Research
Integration of InforSense and E-WorkBook Suites Delivers First Biomarker ELN (Mon, 08 Feb 2010 09:07:40 GMT)
IDBS Launches Biomarker Discovery and Validation Solution to Accelerate Biomarker Research
GUILDFORD, UK and BURLINGTON, MA--(Marketwire - 02/08/10) - IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced the launch of the IDBS Biomarker Discovery and Validation Solution, which streamlines biomarker research and improves collaboration, intellectual property (IP) management and scientific understanding of complex ... (Mon, 08 Feb 2010 09:00:00 GMT)
#Ebook Deal of the Day: R in a Nutshell - Only $9.99! Use discount code DDRNT
R in a Nutshell for only $9.99. Use discount code DDRNT to get your savings!... (Mon, 08 Feb 2010 08:35:49 GMT)
Exercise won't boost endurance levels for 1 in 5
About one in five people can train all they want but, because of their genetic makeup, are not likely to see much improvement in their endurance levels, an international team of researchers reported Thursday. Still, the authors caution, their findings shouldn't be an excuse to throw away the running shoes. "There is a whole host of other physiological responses" to exercise, such as heart rate ... (Mon, 08 Feb 2010 08:02:49 GMT)
IBM Powers Up For Server War
As the Oracle-Sun combo heats up hardware competition, IBM's Power7 servers aim to dominate. (Mon, 08 Feb 2010 06:49:35 GMT)
Searching for Disease Clues in Genetic Diversity
Research on the Mexican genome could broaden the scope of personalized medicine. Over the last few years, scientists have discovered hundreds of genetic variants linked to disease. But the vast majority of that research has focused on people of European, Asian, and African descent. A new effort to catalog genetic diversity among people in Mexico--who along with other Latin Americans have a ... (Mon, 08 Feb 2010 05:18:33 GMT)
Accuri looks to veteran to take it to next level: profitable sale
Having led two Ann Arbor biotech companies to successful sales, Jeffrey Williams hopes to lead another to a profitable exit. (Mon, 08 Feb 2010 01:07:17 GMT)
New test Counsyl focuses on classic genetic diseases
With its focus on classic genetic diseases such as cystic fibrosis, the Counsyl “universal genetic test” has a distinctly “retro” feel to it. Many of the ethical issues raised by this new service are not new but rather present new challenges because of the scale and means of delivery. (Sun, 07 Feb 2010 23:06:35 GMT)
Researchers Use New Approach to Identify Threatened Tuna Species
DNA barcoding is not only a useful taxonomic technique, but it can also help save endangered species and verify the accuracy of your dinner menu, says a study done by researchers at the American Museum of Natural History. (Sun, 07 Feb 2010 21:20:31 GMT)
Gene that improves quality of reprogrammed stem cells identified by Singapore scientists
( Agency for Science, Technology and Research (A*STAR), Singapore ) In Nature, Singapore scientists report that Tbx3 significantly improves quality of induced pluripotent stem cells. (Sun, 07 Feb 2010 18:26:20 GMT)
Rosetta, Ben Gurion University, Alnylam, Medtronic, Silence, Quark
Rosetta Genomics said this week that it has formed a collaboration with Israel’s Ben Gurion University to develop microRNA-targeting therapeutics against several viruses including the Epstein-Barr virus and herpes simplex viruses. (Sun, 07 Feb 2010 17:05:39 GMT)
Meeting Confirms Bioinformatics Status As Key Technology for Pharmaceutical Cos.
LONDON--"Bioinformatics has moved from high potential to key operational technology," remarked Dominic Clark of Glaxo Wellcome at the start of a conference he chaired here February 15-16. (Sun, 07 Feb 2010 17:05:29 GMT)
Admitting Its Limitations, Bio-Rad Contends SELDI Still Valuable for Biomarker Discovery
In their most extensive public comments about the SELDI platform since Bio-Rad Laboratories acquired it from Ciphergen Biosystems last year, officials from Bio-Rad said that despite its shortcomings, the technology is still a valuable tool in the search for biomarkers. (Sun, 07 Feb 2010 17:05:08 GMT)
Fresh fields for AgResearch CEO
Andy West has regularly championed the value of science in agriculture, and leaves his position as chief executive of AgResearch with some business unfinished. (Sun, 07 Feb 2010 16:14:33 GMT)
Genetic tool for sheep, beef breeders
A new genetic product, or SNP Chip, aimed at assisting sheep breeders and Angus beef breeders with molecular breeding values, has been launched in the United States and will be available in New Zealand later this year. (Sun, 07 Feb 2010 16:14:17 GMT)
Biologists determine microRNA activity is suppressed in mouse ovum
Scientists studying RNA activity, the so-called dark matter of the biological world, may have found the first event in reprogramming a differentiated oocyte into pluripotent blastomeres of the embryo. (Sun, 07 Feb 2010 04:24:29 GMT)
SciLi debuts science center
By: Goda Thangada While finishing touches like the installation of smartboards remain, students can begin holding group study sessions and taking advantage of advising in the third-floor science center. The 4,000 square-foot facility, which will have a grand opening in Mar... (Sat, 06 Feb 2010 21:00:57 GMT)
You Could Have the Whole Genome In Your Hand. Do You Want It?
Nestled in the leafy confines of Rockefeller University’s campus on the Upper East Side of Manhattan overlooking the East River, Greg Khitrov’s microarray laboratory is a well-heeled but otherwise typical academic core facility. (Sat, 06 Feb 2010 16:05:49 GMT)
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial terms of the diagnostic agreement have not been ... (Sat, 06 Feb 2010 13:19:08 GMT)
Tracking The Spread Of Disease, Malware And Power Outages
An assistant professor with the Virginia Tech College of Engineering has won a $750,000 federal grant to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to fail. Funded by the U.S... (Sat, 06 Feb 2010 11:22:13 GMT)
TGen Finalizes Alliance With Van Andel Research Institute
The Translational Genomics Research Institute (TGen) has announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes. TGen expects the agreement to create a robust basic-science-to-translational delivery platform aimed at developing new tests and treatments for ... (Sat, 06 Feb 2010 11:21:30 GMT)
Genetics Researcher Ready For Prime Time
If you're a genetic researcher, you're likely familiar with products from Applied Biosystems and Invitrogen, the two companies that merged in November 2008 to form Life Technologies. (Fri, 05 Feb 2010 23:05:32 GMT)
Illumina Says 'Significant Growth' in Sequencing Demand Drove 12-Percent Rise in Q4 Revenue
Illumina this week reported that fourth-quarter revenue increased 12 percent — slightly higher than it projected a few weeks ago — largely resulting from continued growth in sales of its sequencing products. (Fri, 05 Feb 2010 21:50:08 GMT)
In Brief This Week: Bio-Rad Laboratories; TGen, Van Andel Research Institute; Infosys, Elan; Dotmatix, Boehringer ...
NEW YORK (GenomeWeb News) – Bio-Rad Laboratories has completed its offer to exchange up to $300 million aggregate principal amount of its 8 percent Senior Subordinated Notes due 2016 for any and all of its outstanding 8 percent Senior Subordinated Notes due 2016 that were issued in a private placement. (Fri, 05 Feb 2010 21:05:30 GMT)
IP Update
US Patent 7,657,378. Computer-based method for identifying peptides useful as drug targets . Inventors: Samir Kumar Brahmachar; Debasis Dash. Assignee: Council of Scientific & Industrial Research, New Delhi, India. (Fri, 05 Feb 2010 20:50:40 GMT)
Accelrys Sees Revenue Lift in Q3, Breaking Three-Quarter Slide
NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market Thursday that its third-quarter revenues grew 7 percent, breaking a string of revenue declines in the last three consecutive quarters. (Fri, 05 Feb 2010 20:50:29 GMT)
People In The News
NEW YORK (GenomeWeb News) – RainDance Technologies has appointed Sirshendu Roopom Banerjee to be company president and CEO. Banerjee most recently led the Life Science Tools and Diagnostics sector at investment bank Leerink Swann, and he advised healthcare companies at McKinsey and Goldman Sachs. (Fri, 05 Feb 2010 20:50:18 GMT)
Holy Cow
Genomics has revolutionized dairy farming. (Fri, 05 Feb 2010 20:11:04 GMT)
It's No Stretch Shoveling Snow Leads To Injuries
When your driveway is covered in snow this winter, your first thought may be to dig yourself out. But before you grab the shovel, physical therapist Dr. Susan Wainwright shares simple tips to prepare for and avoid injuries from shoveling snow. (Fri, 05 Feb 2010 18:51:19 GMT)
A new Linux flavor for the Cloud
Cloud computing is getting its very own Linux flavor based on the Red-Hat distribution designed expressly for optimizing virtualization technologies like VMware or Xen . CloudLinux (also the name of the startup) can be installed with a single kernel, operating system, and library, and requires only a single copy of Apache which comes bundled with the new distribution. (Fri, 05 Feb 2010 18:20:28 GMT)
UCLA Team Sequences Cell Line, Puts Open Source Software Framework into Production
In their paper, which appeared in last week's PLoS Genetics , the team highlighted "enormous improvements in the throughput of data generation." (Fri, 05 Feb 2010 18:20:18 GMT)
Illumina, Facing Dip in Array Demand, Posts 12-Percent Rise in Q4 Sales
"Significant growth" in demand for high-throughput sequencing products drove Illumina's fourth quarter sales up 12 percent year over year, offsetting a decline in array sales, the company said this week. (Fri, 05 Feb 2010 18:20:08 GMT)
Gentium Announces an Abstract for Defibrotide in the Prevention of Hepatic VOD has been Granted the Prestigious Van ...
VILLA GUARDIA, Italy, Feb. 5 /PRNewswire-FirstCall/ -- Gentium S.p.A. (Fri, 05 Feb 2010 17:13:22 GMT)
A mossy renaissance
The moss field wasn't getting enough respect, a group of researchers believed, and they decided to do something about it (Fri, 05 Feb 2010 16:27:15 GMT)
SEC, Acacia, CombiMatrix, Korea NIH, Affymetrix, Nanogen, Aushon Biosystems, Oxford Gene Technology, RPCI, BlueGnome
The Securities and Exchange Commission has declared that Acacia Research and CombiMatrix can split apart on Aug. 15 after completing a share trade. At that date, every 10 shares of Acacia Research-CombiMatrix common stock will be redeemed for one share of CombiMatrix Corporation common stock. (Fri, 05 Feb 2010 16:05:09 GMT)
NTU researchers complete the world's first in-depth study of the malaria parasite genome
( Nanyang Technological University ) Groundbreaking research done at Singapore's Nanyang Technological University's School of Biological Sciences could lead to the development of more potent drugs or a vaccine for malaria. Assistant Professor Zbynek Bozdech and his team of researchers, including graduate students and post-doctorals from SBS' Division of Genomics & Genetics, have scored a world ... (Fri, 05 Feb 2010 15:27:00 GMT)
EBMT honours abstract on Defibrotide in Hepatic VOD prevention with the Van Bekkum Award
Gentium S.p.A. today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's ... (Fri, 05 Feb 2010 13:31:31 GMT)
TGen And Geisinger Health System Announce Strategic Partnership
The Translational Genomics Research Institute (TGen) and Geisinger Health System have announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference. One of the first projects will focus on the causes of obesity, diabetes and other metabolic conditions. Researchers plan to look at the ... (Fri, 05 Feb 2010 12:37:21 GMT)
Gentium Announces an Abstract for Defibrotide in the Prevention of Hepatic VOD has been Granted the Prestigious Van ...
Gentium S.p.A. today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's ... (Fri, 05 Feb 2010 12:30:00 GMT)
Biomedical Research: Finland Invests 1.85 Million Euros In Pan-European Infrastructure
Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M euros is to support preparation and pilot studies in 2010. This funding is meant to ensure Finland's ... (Fri, 05 Feb 2010 11:34:08 GMT)
Press Release
Pfizer Inc. Posted on:05 Feb 10 Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial terms of the ... (Fri, 05 Feb 2010 09:20:52 GMT)
Results validating performance of GSN’s proprietary Parental Support technology published
Gene Security Network, Inc (GSN) today announced that Human Reproduction published results validating the exceptional performance of GSN’s proprietary Parental SupportTM technology over existing methods to detect chromosome abnormalities during in vitro-fertilization (IVF). (Fri, 05 Feb 2010 09:17:01 GMT)
Virginia Tech professor wins grant to formulate mathematical framework for flu prevention
An assistant professor with the Virginia Tech College of Engineering has won a $750,000 federal grant to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to fail. (Fri, 05 Feb 2010 09:01:42 GMT)
TGen completes strategic alliance and affiliation agreement with VARI
The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes. (Fri, 05 Feb 2010 08:16:31 GMT)
TGen finalizes alliance with Van Andel Research Institute
( The Translational Genomics Research Institute ) The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both nonprofit institutes. (Fri, 05 Feb 2010 07:19:22 GMT)
Arrayit's VIP DNA testing technology receives patent protection in Israel
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea ... (Fri, 05 Feb 2010 05:31:41 GMT)
Holloway competition jumpstarts student businesses
By: Krista Macomber Now in its 22nd year, the Holloway Prize Innovation-to-Market Competition offers graduate and undergraduate students at the University of New Hampshire, Keene State College and Plymouth State University the chance to win up to $10,000 in seed money t... (Fri, 05 Feb 2010 04:21:36 GMT)
Finland Commits $2.6M to European Research Infrastructure to Link Bfx, Biobanking, Translational Research
Finland has pledged $2.6 million (€1.85 M) to help develop European biomedical research infrastructure, which will help support a joint pilot infrastructure project in bioinformatics, biobanking, and translational research, the European Molecular Biology Laboratory said said in a statement. (Fri, 05 Feb 2010 04:20:08 GMT)
Centre to Tackle Big Issues in 2010 Research gathe
A range of internationally recognised scientists, including Professor Sir Peter Gluckman, will address a range of cutting edge issues in reproductive and genetic science at the second Annual Scientific Research Colloquium held by the Centre for Reproduction and Genomics (CRG) a collaboration between the University of Otago and AgResearch, New Zealand’s leading primary industry research ... (Fri, 05 Feb 2010 00:53:05 GMT)
New computational tool for cancer treatment
Researchers have developed an approach for creating new IDO inhibitors by computer-assisted structure-based drug design. (Fri, 05 Feb 2010 00:23:58 GMT)
Luminex Corporation Reports Fourth Quarter and Full Year 2009 Results
AUSTIN, Texas, Feb. 4 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the fourth quarter and year ended December 31, 2009. (Fri, 05 Feb 2010 00:04:32 GMT)
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary ... (Thu, 04 Feb 2010 21:10:55 GMT)
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2009
SAN DIEGO----Illumina, Inc. today announced its financial results for the fourth quarter and fiscal year of 2009. (Thu, 04 Feb 2010 21:05:00 GMT)
Luminex Corporation Reports Fourth Quarter and Full Year 2009 Results
Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2009. Recent financial and operating highlights include the following: (Thu, 04 Feb 2010 21:01:00 GMT)
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
MANCHESTER, England & NEW YORK----Pfizer Inc. and DxS today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 , an immunotherapy vaccine in development for the treatment of glioblastoma multiforme . (Thu, 04 Feb 2010 21:00:00 GMT)
Product Watch
EMLab P&K, a TestAmerica company, has launched new analytical services to detect pathogens in food and environmental samples using real-time PCR technology. (Thu, 04 Feb 2010 19:05:13 GMT)
Researcher to track spread of disease, malware and power outages
An assistant professor with the Virginia Tech College of Engineering has won a $750,000 federal grant to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to fail. (Thu, 04 Feb 2010 18:22:59 GMT)
This Week in Nature
In this week's issue of Nature , a UK research team reports that they have identified large, rare chromosomal copy number changes linked to early obesity . In a group of 300 Caucasian individuals with early onset obesity, including 143 with developmental delays, the researchers found recurrent, rare deletions of various sizes affecting a chromosome 16 region called 16p11.2 — previously tied to ... (Thu, 04 Feb 2010 18:20:08 GMT)
Researcher to track spread of disease, malware and power outages
( Virginia Tech ) An assistant professor with the Virginia Tech College of Engineering has won a Department of Energy Early Career Award to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to ... (Thu, 04 Feb 2010 17:30:40 GMT)
At Close to No Cost
George Whitesides discusses using paper-based devices for medical tests for use in the developing world and in conflict zones. Almutairi"s lab is focused on utilizing and advancing bionanotechnology to detect, treat and prevent diseases mitigating their huge social and economic costs. (Thu, 04 Feb 2010 16:35:28 GMT)
CAREERS: Making It Easy on the Reviewer
At Effect Measure, Revere takes a break from an all-consuming grant application to discuss how to make reading the proposal easy on the reviewer — which hopefully makes your application more successful . "My goal is always to write the grant in such a way that it writes its own review. (Thu, 04 Feb 2010 16:35:18 GMT)
LabCorp Pens Cancer Dx-Development Deal With CancerGuide Diagnostics
According to CancerGuide, its initial tests will be designed to help physicians assess the risk of cancer recurrence and for therapy selection. (Thu, 04 Feb 2010 16:35:08 GMT)
What Else is New?, It Should Be Titled
A National Science Foundation report says the US is at risk of losing its status as a leader in science and technological innovation, says a New York Times article . As science and technology flourishes outside the US, domestic science education lags and many Americans remain ignorant of basic science -- or, refuse to accept basic scientific tenets like evolution and the Big Bang. The report ... (Thu, 04 Feb 2010 16:06:30 GMT)
What, No Big Names Could Make It?
Bill Gates, Eric Lander, Maynard Olson, Leena Peltonen, and George Church led a panel discussion on personal genomics at the University of Washington on Wednesday night, covering the state of genomics and the effect of studies linking genetic variation to disease. (Thu, 04 Feb 2010 16:06:20 GMT)
Darwin's Handwriting Would Make Our Mothers Cry
"Darwin had difficult handwriting ," writes PZ Myers. The Darwin Online collection has digital versions of Charles Darwin's notes and letters. Taking a look at this outline of his species theory, Darwin's handwriting does indeed look spidery and small, with cross-outs and sideways notes. (Thu, 04 Feb 2010 16:06:10 GMT)
GeneOhm to Acquire Infectio Diagnostic; Company Will Receive $12M VC Cash Infusion
NEW YORK, Oct. 21 (GenomeWeb News) - Microarray company GeneOhm Sciences will acquire Infectio Diagnostic in a stock swap expected to close in November, the firms said today. (Thu, 04 Feb 2010 16:05:50 GMT)
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
FDA granted the authorization in a Jan. 21 letter to Lee's Summit, Mo.-based ViraCor. The letter was made available ion the agency's web site this week. (Thu, 04 Feb 2010 16:05:15 GMT)
Research and Markets: Bioinformatics for Glycobiology and Glycomics: an Introduction
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Bioinformatics for Glycobiology and Glycomics: An Introduction" to their offering. (Thu, 04 Feb 2010 13:54:00 GMT)
Geisinger And TGen Announce Strategic Partnership To Shape Future Of Personalized Medicine
Geisinger Health System and the Translational Genomics Research Institute (TGen) announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference. One of the first projects will focus on the causes of obesity, diabetes and other metabolic conditions. Researchers plan to look at the possible ... (Thu, 04 Feb 2010 12:41:55 GMT)
The Translational Genomics Research Institute Partners With Cambridge, UK, Firm In Cancer Research
The Translational Genomics Research Institute (TGen) and Horizon Discovery have announced plans to develop human disease models for use in TGen's cancer research. A research-collaboration and sub-licensing agreement will allow TGen investigators to use Horizon's GENESIS™ and X-MAN™ technologies to accelerate the search for new drug targets, biomarkers and anti-cancer agents, which could provide ... (Thu, 04 Feb 2010 11:41:45 GMT)
Finland commits 1.85M as initial funding for development of European biomedical research infrastructures
Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M- is to support preparation and pilot studies in 2010. (Thu, 04 Feb 2010 08:32:07 GMT)
Pall Corporation Introduces The PallSep Biotech Filtration System For Difficult-To-Process Biotechnology Feed Streams
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids. (Thu, 04 Feb 2010 07:42:00 GMT)
USPTO issues three patents to Rosetta Genomics
Rosetta Genomics today announced that the United States Patent and Trademark Office (USPTO) has issued three patents to the company covering the composition of matter of human microRNAs. (Thu, 04 Feb 2010 07:31:57 GMT)
Pall Corporation Introduces The PallSep Biotech Filtration System For Difficult-To-Process Biotechnology Feed Streams
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids. (Thu, 04 Feb 2010 07:24:23 GMT)
Geisinger Health System and TGen sign research agreement
Geisinger Health System and the Translational Genomics Research Institute (TGen) today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference. (Thu, 04 Feb 2010 06:02:58 GMT)
P&G joins existing Navigenics investors in $18M Series C financing
Navigenics, a leading personal genomics company, announced today that the company has raised approximately $18 million of funding. The Procter and Gamble Company, with a worldwide portfolio of leading consumer brands, has joined existing Navigenics investors Kleiner Perkins Caufield and Byers and Mohr Davidow Ventures who also participated in this financing round. (Thu, 04 Feb 2010 05:46:57 GMT)
TGen, Geisinger Health System sign strategic research agreement
The Translational Genomics Research Institute (TGen) and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference. (Thu, 04 Feb 2010 05:31:47 GMT)
SDSU Provides Web Tool for Plant Breeders
A new Web-based tool at South Dakota State University helps plant breeders & researchers worldwide analyze molecular data to select best grapes & other plant stock to breed better plants. (Thu, 04 Feb 2010 01:40:39 GMT)
Penn Biologists Determine MicroRNA Activity Is Suppressed in Mouse Ovum
Biologists at the University of Pennsylvania studying oocytes in mice, the immature egg cells necessary for sexual reproduction, have demonstrated an unusual behavior in microRNA, or miRNA, activity that may be the first event in reprogramming the differentiated oocyte into pluripotent blastomeres of the embryo. (Thu, 04 Feb 2010 01:08:57 GMT)
TGen Partners with Geisinger on Obesity Research
NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute will partner with Geisinger Health System in Pennsylvania in an effort that will use genomics technologies and clinical data to discover causes of obesity, diabetes, and other metabolic conditions. (Wed, 03 Feb 2010 23:35:29 GMT)
Affymetrix's Q4 Sales Surge 13 Percent
NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market Wednesday that its fourth-quarter revenues increased 13 percent, driven by a 30 percent increase in sales of its genotyping products. (Wed, 03 Feb 2010 23:35:08 GMT)
University of Pittsburgh Earmarks $350K from NIH Grant for WaferGen Real-Time PCR Studies
Wafergen Biosystems said this week that researchers at the University of Pittsburgh have earmarked $350,000 from an NIH grant to pay for research that will use Wafergen's SmartChip real-time PCR system as part of a larger multi-institution study on the genomics of chronic lung disease. (Wed, 03 Feb 2010 22:20:08 GMT)
Recent Research Papers of Note
The authors recently introduced a method to facilitate the analysis of phosphopeptides by performing automated online TiO 2 enrichment of phosphopeptides prior to MS analysis. (Wed, 03 Feb 2010 22:05:11 GMT)
NextGen Developing Biomarker Assays for Takeda
Biomarker firm NextGen Sciences this week announced it has entered into an agreement with Takeda Pharmaceutical to develop validated protein biomarker assays. (Wed, 03 Feb 2010 21:20:28 GMT)
Oxford Nanopore Raises $28 Million to Start Protein Analysis Work, Continue DNA Sequencing Research
Oxford Nanopore Technologies announced this week it has raised £17.4 million ($28 million) which it will use to start work in protein analysis, in addition to "accelerated" development of its core technology for DNA sequencing and continued work in its lead project in DNA sequencing. (Wed, 03 Feb 2010 21:20:18 GMT)
Atlas Biolabs to Offer Roche NimbleGen Target-Enrichment, Sequencing Services
Roche NimbleGen said today that it has certified genomics service provider Atlas Biolabs to provide target-enrichment and sequencing services using its technologies. (Wed, 03 Feb 2010 21:20:08 GMT)
Vermillion Closes Settlement Debt with HDC
NEW YORK (GenomeWeb News) – Health Discovery Corp. today said that it has received the final payment owed to it by Vermillion under a patent infringement lawsuit. (Wed, 03 Feb 2010 21:05:21 GMT)
Navigenics Nets $18M in Financing Round
NEW YORK (GenomeWeb News) – Navigenics has reeled in $18 million in Series C financing from an investment round that included The Procter and Gamble Company, Kleiner Perkins Caufield and Byers, and Mohr Davidow Ventures. (Wed, 03 Feb 2010 21:05:12 GMT)
Dr. Klaus Lindpaintner Begins Serving as Vice President of R&D and CSO for Strategic Diagnostics
NEWARK, Del.----SDI , a provider of biotechnology-based products and services, today announced that Dr. Klaus Lindpaintner began serving as Vice President of Research & Development and Chief Scientific Officer on February 1, 2010 as previously disclosed in its January 11, 2010 news release. (Wed, 03 Feb 2010 21:02:00 GMT)
Livestock Genomics, Breeding Wins $11M from USDA
NEW YORK (GenomeWeb News) –The US Department of Agriculture has awarded nearly $11 million in grants to genomics and genetics studies focused on livestock animal development and breeding. (Wed, 03 Feb 2010 20:50:08 GMT)
Roche NimbleGen Array Sales Rise 44 Percent in '09
Sales of Roche NimbleGen arrays rose 44 percent in 2009 compared to 2008, fueled by "continued strong performance" of Roche NimbleGen's sequence capture arrays as well as the introduction of its high-throughput MS 200 microarray scanner, according to the firm, the company said this week. (Wed, 03 Feb 2010 20:20:10 GMT)
Scientists map epigenome of human stem cells during development
( Agency for Science, Technology and Research (A*STAR), Singapore ) Singapore and US scientists have mapped major components of the epigenome and DNA methylation for the entire human DNA sequence, and compared three cell types representing three stages of human development. (Wed, 03 Feb 2010 19:26:20 GMT)
Simbios Molecular Dynamics workshop
On March 1-2, Simbios , the NIH Center for physics-based Simulation of Biological Structures at Stanford University, will be hosting the Molecular Dynamics Workshop Series . The first workshop will cover running and developing MD algorithms on GPUs with OpenMM , a programming library which provides tools for molecular modeling simulation, and PyOpenMM , the Python version of OpenMM. (Wed, 03 Feb 2010 18:35:08 GMT)
Penn biologists determine microRNA activity is suppressed in mouse ovum
( University of Pennsylvania ) Scientists studying RNA activity, the so-called dark matter of the biological world, may have found the first event in reprogramming a differentiated oocyte into pluripotent blastomeres of the embryo. (Wed, 03 Feb 2010 17:34:38 GMT)
Geisinger and TGen Announce Strategic Partnership to Shape Future of Personalized Medicine
Geisinger Health System and the Translational Genomics Research Institute (TGen) today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference. (Wed, 03 Feb 2010 17:20:56 GMT)
TGen and Geisinger Health System announce strategic partnership
( The Translational Genomics Research Institute ) The Translational Genomics Research Institute and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference. (Wed, 03 Feb 2010 17:19:22 GMT)
Helicos to Install Second Sequencer at Stanford; Sells Instrument to Private Research Institute
Helicos BioSciences said today that it will install a second Helicos Genetic Analysis system at Stanford University, and that it has sold an instrument to a private research institute, a deal originally announced a year ago. (Wed, 03 Feb 2010 17:05:11 GMT)
In ACLU v. Myriad, It's Scientific Accuracy, 0, and Wild Speculation, 1
Unless you've been living under a sequencer, you already know that the ACLU v. Myriad gene patent hearings began yesterday . Daily Scan was there for the circus, held in a standing-room-only courtroom in downtown New York. The ACLU attorneys spent much of their time arguing that isolated DNA was not "markedly different" from native DNA, and therefore not eligible for patent protection. (Wed, 03 Feb 2010 16:35:20 GMT)
This Week in Genome Research
In the early, online edition of Genome Research this week, MD Anderson Cancer Center researcher Jean-Pierre Issa and his team found DNA methylation levels shifts at some genes in aging mouse tissues. (Wed, 03 Feb 2010 16:35:10 GMT)
Talking Genomic Medicine and More
Science Progress is encouraged by the upcoming meeting of the Secretary’s Advisory Committee for Genetics, Health, and Society at the Department of Health and Human Services, saying that this sort of federal-level discussion of the future of genomic medicine is just what is needed. (Wed, 03 Feb 2010 16:20:50 GMT)
Molecular Devices Returns to Life Sciences Marketplace
SUNNYVALE, Calif., Feb. 3 /PRNewswire/ -- Today, Molecular Devices, Inc.--now part of Danaher Corporation--re-launched the Molecular Devices brand into the life sciences marketplace. (Wed, 03 Feb 2010 16:14:32 GMT)
Finland Adds $2.6M for European Translational Research Effort
NEW YORK (GenomeWeb News) – Finland has invested €1.9 million ($2.6 million) to support a pan-European pilot project that will involve bioinformatics, biobanking, and translational research efforts in order to ensure that its scientists are involved in developing European biomedical infrastructures, the European Molecular Biology Laboratory (MBL) said today. (Wed, 03 Feb 2010 16:06:01 GMT)
Finland invests 1.85 million in pan-European infrastructure for biomedical research
( University of Helsinki ) Finland has made its first specific commitment to the development of European biomedical research infrastructures by supporting a joint pilot infrastructure project in bioinformatics, biobanking and translational research. The initial commitment of 1.85 ($2.6) million is to support preparation and pilot studies in 2010. (Wed, 03 Feb 2010 14:40:56 GMT)
ATLAS Biolabs GmbH Joins Roche NimbleGen's Certified Service Provider Program for Targeted Enrichment
MADISON, Wis.----Roche NimbleGen has announced that ATLAS Biolabs GmbH, a Berlin, Germany-based company, has officially become a Certified Service Provider for NimbleGen Sequence Capture. (Wed, 03 Feb 2010 13:00:00 GMT)
Rosetta Genomics Announces Issuance of Three U.S. Patents
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics today announced that the United States Patent and Trademark Office has issued three patents to the company covering the composition of matter of human microRNAs. (Wed, 03 Feb 2010 12:30:00 GMT)
• Nutrition expert lectures in Kannapolis
By Emily Ford eford@salisburypost.com KANNAPOLIS â Nutrition scientists at the N.C. Research Campus are working to discover and document genetic differences in people, so doctors can create personalized diets for their patients. Called "individual ... (Wed, 03 Feb 2010 12:25:04 GMT)
Navigenics Raises $18 Million in Series C Financing
FOSTER CITY, Calif.----Navigenics, a leading personal genomics company, announced today that the company has raised approximately $18 million of funding. The Procter and Gamble Company, with a worldwide portfolio of leading consumer brands, has joined existing Navigenics investors Kleiner Perkins Caufield and Byers and Mohr Davidow Ventures who also participated in this financing round. (Wed, 03 Feb 2010 12:00:00 GMT)
Set platform for harnessing synergy: Guv
Port Blair, Feb 3 : Andaman and Nicobar Islands Lt Governor Bhopinder Singh today urged all the research institutions of the islands to set up a suitable platform for harnessing synergy among different research institutions for the betterment of the islanders. (Wed, 03 Feb 2010 11:35:54 GMT)
New Way To Screen Libraries Of 10 Million Or More Compounds
The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through - time and money make it virtually impossible to screen or search through super-large libraries of potential compounds. This is a serious problem, because there is enormous interest in identifying synthetic molecules that ... (Wed, 03 Feb 2010 11:27:13 GMT)
CLC bio expands bioinformatics consulting organization in North America
CLC bio announced the expansion of North American consulting organization. The organization, based in Washington, will function as an integrated part of CLC bio's global consulting team. (Wed, 03 Feb 2010 10:43:46 GMT)
TGen, Horizon Discovery partner in development of novel cancer cell-lines
The Translational Genomics Research Institute (TGen) and Horizon Discovery today announced plans to develop human disease models for use in TGen's cancer research. (Wed, 03 Feb 2010 09:32:36 GMT)
New resources to support Teva Pharmaceutical Industries' Tjet injector system now available
Teva Pharmaceutical Industries Ltd. announced today the availability of new resources to support the recently introduced Tjet® injector system, a needle-free device designed to deliver Teva’s TEV-TROPIN® [somatropin (rDNA origin) for injection] brand human growth hormone (hGH) to children who have growth failure due to inadequate secretion of normal endogenous growth hormone. (Wed, 03 Feb 2010 09:18:57 GMT)
UCR purchases Nikon BioStation CT technology to assist in stem cell research
Stem cell research at the University of California, Riverside is about to gather speed thanks to the establishment of a new Stem Cell Core Facility (SCCF) - a shared facility providing infrastructure, equipment, and trained personnel for doing stem cell research that ordinarily would not be available in most laboratories. (Wed, 03 Feb 2010 09:04:08 GMT)
Molecular Devices Returns to Life Sciences Marketplace
SUNNYVALE, California, February 3 /PRNewswire/ -- - New Brand Launched by Molecular Devices, Inc. SUNNYVALE, California, February 3 /PRNewswire/ -- Today, Molecular Devices, Inc.-now part of Danaher Corporation-re-launched the Molecular Devices brand into the life sciences marketplace. (Wed, 03 Feb 2010 08:41:47 GMT)
Angrist demystifies genomics
It’s flashy, it’s new, it’s the hottest thing on the market. (Wed, 03 Feb 2010 08:14:19 GMT)
10 new kits available for fast and simple isolation of nucleic acids from blood, plasma and serum
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 10 new kits for the fast and simple isolation of nucleic acids from blood, plasma and serum, including circulating nucleic acids. (Wed, 03 Feb 2010 06:47:17 GMT)
OGT Launches New ISCA-Endorsed Cytosure™ Acgh Arrays For Detecting Disease And Syndrome-Related Aberrations
Oxford Gene Technology (OGT), the pioneer of microarray-based technologies, has introduced three new CytoSure™ ISCA aCGH arrays to meet all resolution, multiplexing and budget requirements. (Wed, 03 Feb 2010 06:26:50 GMT)
Genetic test for 'speed gene' in thoroughbred horses
Groundbreaking research led by a leading horse genomics scientist in Ireland has resulted in the identification of the 'speed gene' in thoroughbred horses. (Wed, 03 Feb 2010 03:27:13 GMT)
Bioinformatics – bringing IT and life sciences together
Imagine trying to work through millions of bits of information, attempting to work out why a cell had suddenly turned cancerous, or why, in a population of one billion, some individuals started smoking, while others did not? (Wed, 03 Feb 2010 03:14:14 GMT)
Dr. Cohan Studies Mutations, Promiscuous Sex in Bacteria
Bacteria are weird. (Wed, 03 Feb 2010 02:12:51 GMT)
Millipore's Q4 Revenues up 7 Percent with Currency Boost
NEW YORK (GenomeWeb News) – Millipore reported after the close of the market Tuesday that its fourth-quarter revenues climbed 7 percent, aided by a 5 percent benefit from foreign currency translation. (Tue, 02 Feb 2010 23:35:19 GMT)
Myriad Genetics' Q2 Revenues Rise 11 Percent; Profit up 67 Percent
NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that its second-quarter revenues climbed 11 percent due primarily to increased sales and marketing efforts and improved physician acceptance of its products. (Tue, 02 Feb 2010 23:35:08 GMT)
IP Update: Recent Patents Related to PCR, Sample Prep, and Nucleic Acid Amplification
US Patent No. 7,655,791. DNA amplification and sequencing using DNA molecules generated by random fragmentation . Inventors: Vladimir Makarov, Irina Sleptsova, Emmanuel Kamberov, Eric Bruening. Assignee: Rubicon Genomics. (Tue, 02 Feb 2010 20:35:28 GMT)
France's Institut Pasteur Develops Resequencing Array for Pathogen Identification
Researchers at the Institut Pasteur's Laboratory for Urgent Response to Biological Threats in Paris have developed a new resequencing microarray for use in public health emergencies triggered by exposure to pathogens. (Tue, 02 Feb 2010 20:35:18 GMT)
